Voriconazole is primarily used as an antifungal medication to treat serious fungal infections. It is effective against a wide range of fungal pathogens, including Aspergillus, Candida, and certain rare fungi. The drug is commonly administered to patients with invasive aspergillosis, a severe infection that often affects immunocompromised individuals, such as those undergoing chemotherapy or organ transplantation. It is also used to treat esophageal candidiasis, a fungal infection of the esophagus, and candidemia, a bloodstream infection caused by Candida species. In addition, voriconazole is employed as a prophylactic treatment to prevent fungal infections in high-risk patients. Its broad-spectrum activity and ability to penetrate tissues, including the central nervous system, make it a valuable option for managing systemic fungal infections. However, its use requires careful monitoring due to potential side effects and drug interactions.